Thorac Cardiovasc Surg 2018; 66(08): 637-644
DOI: 10.1055/s-0037-1603790
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Postoperative Complications and Long-Term Results after Primary Cardiac Sarcoma Resection

Erhan Kavakbasi
1   Department of Psychiatry and Psychotherapy, University of Münster, Münster, Germany
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
Hans Heinrich Scheld
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
Torsten Kessler
3   Department of Medicine A, University of Münster, Münster, Germany
,
Jürgen R. Sindermann
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
Volkan Kösek
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
T. D. T. Tjan
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
Sven Martens
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
,
Andreas Hoffmeier
2   Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Münster, Münster, Germany
› Author Affiliations
Further Information

Publication History

14 February 2017

30 April 2017

Publication Date:
11 June 2017 (online)

Abstract

Background Primary malignant cardiac tumors rarely occur in clinical care. Little is known about the impact of a parameter on postoperative survival.

Methods From May 1991 to May 2014, a total of 24 patients underwent surgical treatment of a primary cardiac sarcoma in our center. We analyzed our clinical database retrospectively for information on patient characteristics and treatment data. The follow-up could be completed to 91.7%.

Results Angiosarcoma and non-otherwise-specified sarcoma were the most common tumor entities. R0 resection was achieved in most cases. Postoperative mortality within the first 30 days was 20.8% (n = 5). In four of these five cases, postoperative low-output cardiac failure was the leading cause of death. The cumulative survival rate was 77.3% after 30 days, 68.2% after 3 months, 50.0% after 6 months, 45.0% after 12 months, and 18.0% after 24 months. The mean survival time in the whole group was 47.0 months. A low tumor differentiation was associated with low mean survival, but this was not statistically significant. Mean survival of sarcoma was higher after R0 resection. There was no significant rate of survival difference regarding the adjuvant therapy concept.

Conclusion Extended surgery alone or in combination with chemo- and/or radiotherapy may be successful in certain cases and may offer a satisfactory quality of life. The establishment of a multicenter heart tumor register in Germany is necessary to increase the number of cases in studies, get more remarkable study results, and standardize the diagnosis and therapy.

 
  • References

  • 1 Castillo JG, Silvay G, Boateng P. Characterization of surgical cardiac tumors. Bratisl Lek Listy (Tlacene Vyd) 2016; 117 (01) 3-10
  • 2 Rafajlovski S, Tatić V, Ilić S, Kanjuh V. [Frequency of metastatic tumors in the heart]. Vojnosanit Pregl 2005; 62 (12) 915-920
  • 3 Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol 2005; 6 (04) 219-228
  • 4 Yu L, Gu T, Shi E. , et al. Primary malignant cardiac tumors. J Cancer Res Clin Oncol 2014; 140 (06) 1047-1055
  • 5 Kim MP, Correa AM, Blackmon S. , et al. Outcomes after right-side heart sarcoma resection. Ann Thorac Surg 2011; 91 (03) 770-776
  • 6 Pacini D, Careddu L, Pantaleo A. , et al. Primary malignant tumors of the heart: Outcomes of the surgical treatment. Asian Cardiovasc Thorac Ann 2015; 23 (06) 645-651
  • 7 Barreiro M, Renilla A, Jimenez JM. , et al. Primary cardiac tumors: 32 years of experience from a Spanish tertiary surgical center. Cardiovasc Pathol 2013; 22 (06) 424-427
  • 8 Burazor I, Aviel-Ronen S, Imazio M. , et al. Primary malignancies of the heart and pericardium. Clin Cardiol 2014; 37 (09) 582-588
  • 9 Hudzik B, Miszalski-Jamka K, Glowacki J. , et al. Malignant tumors of the heart. Cancer Epidemiol 2015; 39 (05) 665-672
  • 10 Krombach GA, Spuentrup E, Buecker A. , et al. Heart tumors: magnetic resonance imaging and multislice spiral CT [in German]. RoFo Fortschr Geb Rontgenstr Nuklearmed 2005; 177 (09) 1205-1218
  • 11 Rahbar K, Seifarth H, Schäfers M. , et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med 2012; 53 (06) 856-863
  • 12 Nijjar PS, Masri SC, Tamene A, Kassahun H, Liao K, Valeti U. Benefits and limitations of multimodality imaging in the diagnosis of a primary cardiac lymphoma. Tex Heart Inst J 2014; 41 (06) 657-659
  • 13 Sharma S, Sundaram U, Loya Y. Selective coronary angiography in intracardiac tumors. J Interv Cardiol 1993; 6 (02) 125-129
  • 14 Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int 2014; 111 (12) 205-211
  • 15 Hoffmeier A, Schmid C, Deiters S. , et al. Neoplastic heart disease -- the Muenster experience with 108 patients. Thorac Cardiovasc Surg 2005; 53 (01) 1-8
  • 16 Hoffmeier A, Scheld HH, Tjan TD. , et al. Ex situ resection of primary cardiac tumors. Thorac Cardiovasc Surg 2003; 51 (02) 99-101
  • 17 Ramlawi B, Al-Jabbari O, Blau LN. , et al. Autotransplantation for the resection of complex left heart tumors. Ann Thorac Surg 2014; 98 (03) 863-868
  • 18 Uberfuhr P, Meiser B, Fuchs A. , et al. Heart transplantation: an approach to treating primary cardiac sarcoma?. J Heart Lung Transplant 2002; 21 (10) 1135-1139
  • 19 Hoffmeier A, Deiters S, Schmidt C. , et al. Radical resection of cardiac sarcoma. Thorac Cardiovasc Surg 2004; 52 (02) 77-81
  • 20 Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113 (03) 573-581
  • 21 Woll PJ, Reichardt P, Le Cesne A. , et al; EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012; 13 (10) 1045-1054
  • 22 ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25 (Suppl. 03) iii102-iii112
  • 23 Abu Saleh WK, Ramlawi B, Shapira OM. , et al. Improved outcomes with the evolution of a neoadjuvant chemotherapy approach to right heart sarcoma. Ann Thorac Surg 2017 Doi: 10.1016/j.athoracsur.2016.10.054
  • 24 O'Neal JB, Shaw AD, Billings IV FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care 2016; 20 (01) 187
  • 25 Singer M, Deutschman CS, Seymour CW. , et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
  • 26 Habertheuer A, Laufer G, Wiedemann D. , et al. Primary cardiac tumors on the verge of oblivion: a European experience over 15 years. J Cardiothorac Surg 2015; 10: 56
  • 27 Saraiva J, Antunes PE, Carvalho L, Antunes MJ. Primary malignant cardiac tumors: surgical results [in Portuguese]. Rev Port Cardiol 2016; 35 (04) 199-204
  • 28 Dias RR, Fernandes F, Ramires FJ, Mady C, Albuquerque CP, Jatene FB. Mortality and embolic potential of cardiac tumors. Arq Bras Cardiol 2014; 103 (01) 13-18
  • 29 Isambert N, Ray-Coquard I, Italiano A. , et al. Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group. Eur J Cancer 2014; 50 (01) 128-136
  • 30 Randhawa JS, Budd GT, Randhawa M. , et al. Primary cardiac sarcoma: 25-year Cleveland Clinic experience. Am J Clin Oncol 2016; 39 (06) 593-599
  • 31 Hamidi M, Moody JS, Weigel TL, Kozak KR. Primary cardiac sarcoma. Ann Thorac Surg 2010; 90 (01) 176-181
  • 32 Ramlawi B, Leja MJ, Abu Saleh WK. , et al. Surgical treatment of primary cardiac sarcomas: review of a single-institution experience. Ann Thorac Surg 2016; 101 (02) 698-702
  • 33 Bruckner BA, Abu Saleh WK, Al Jabbari O. , et al. Total artificial heart implantation after excision of right ventricular angiosarcoma. Tex Heart Inst J 2016; 43 (03) 252-254